New research leads to FDA approval of first drug to treat radiation sickness

New research has led to FDA approval of the use of a drug to treat the effects of radiation exposure following a nuclear incident. The drug, Neupogen, is the first ever approved for the treatment of acute radiation injury.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1HqGIGD

No comments:

Post a Comment